Source · Select Committees · Women and Equalities Committee
Recommendation 33
33
Acknowledged
Paragraph: 121
Evaluate merits of nationally rolling out the anti-mullarian hormone blood test for PCOS diagnosis.
Conclusion
The approval of the anti-mullarian hormone blood test as another tool to assist in the diagnosis of polycycstic ovary syndrome is a welcome development. NHS England should evaluate the merits of rolling it out nationally as a matter of priority.
Government Response Summary
The government stated it is working to take forward the Women’s Health Strategy for England and will consider the committee's recommendations on topics and key indicators, including the evaluation of the anti-mullarian hormone blood test, as part of this ongoing work.
Paragraph Reference:
121
Government Response
Acknowledged
HM Government
Acknowledged
We are working with NHS England and the Women’s Health Ambassador on how we take forward the Women’s Health Strategy for England (linked in ‘Introduction’ above) by aligning it to the government’s missions and forthcoming 10 Year Health Plan. We will consider the committee’s recommendations on topics for inclusion and key indicators as we take this work forward.